Extracted from this filing and checked against the source text.
Listing & Compliance Notices
SEC 8-K Item 3.01
confidence 0.9
ModivCare Inc received a nasdaq delisting notice notice regarding other (rules 5101, 5110(b), IM-5101-1).
- Exchange
- nasdaq
- Notice
- delisting notice
- Rules
- 5101, 5110(b), IM-5101-1
Exact text from the filing
August 21, 2025, ModivCare Inc. (the “Company”) received a notification letter (the “Delisting Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that Nasdaq had determined to commence proceedings to delist the Company’s common stock, $0.001 par value per share (the “Common Stock”), from Nasdaq. Nasdaq reached its decision that the Company is no longer suitable for listing pursuant to Nasdaq Listing Rules 5101, 5110(b), and IM-5101-1 as a result of the Company’s commencement of voluntary proceedings under Chapter 11 of the United
View on SEC.gov
Listing & Compliance Notices
SEC 8-K Item 3.01
confidence 0.9
ModivCare Inc received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).
- Exchange
- nasdaq
- Notice
- noncompliance notice
- Deficiency
- late filing
- Rules
- 5250(c)(1)
Exact text from the filing
August 20, 2025. In addition, on August 20, 2025, the Company received a notification letter (the “Delinquency Notice”) from Nasdaq notifying the Company that, because the Company is delinquent in filing its Quarterly Report on Form 10-Q for the period ended June 30, 2025, the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires companies with securities listed on Nasdaq to timely file all required periodic reports with the Securities and Exchange Commission (the “SEC”). Nasdaq informed the Company that the Common Stock would be suspended at the opening of business
View on SEC.gov